Mark Alles
Director/Board Member chez BIOMARIN PHARMACEUTICAL INC.
Fortune : 1 M $ au 31/03/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jonathan Biller | M | 61 |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | 9 ans |
Christopher Bahl | M | - |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | 3 ans |
Jean-Jacques Bienaimé | M | 70 | 19 ans | |
John McKearn | M | 70 |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | - |
Peter Kellogg | M | 67 | 6 ans | |
Barbara Bodem | F | 56 | 3 ans | |
John F. Chin | M | 58 |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | 26 ans |
David Licata | M | - |
TORL Biotherapeutics LLC
TORL Biotherapeutics LLC BiotechnologyHealth Technology TORL Biotherapeutics LLC is a clinical-stage biopharmaceutical company based in Culver City, CA. TORL Biotherapeutics LLC is focused on developing new antibodies, including monoclonal antibodies (mAbs) and drug conjugates (ADCs), to transform the lives of patients with various types of cancer. TORL has a strategic partnership with the Slamon Research Lab and has exclusive rights to a program of biologics-based drugs for novel cancer targets. The company's lead program, TORL-1-23, is an ADC directed towards cldn6 for patients with multiple cancers. In addition to this, TORL has four other clinical-stage antibody programs and is building a pipeline of novel ADCs and mAbs for cancers with high unmet medical needs. The company was founded by David Licata, and the CEO is Mark J. Alles. | - |
Katherine Reynolds Kelly | F | 48 | 5 ans | |
Alexander Hardy | M | 56 | 1 ans | |
Kumar Srinivasan | M | 59 |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | 1 ans |
David Elkins | M | 55 | 6 ans | |
Conley Chee | M | 54 | 3 ans | |
Sandra Ramos-Alves | F | - | 2 ans | |
Noah Beerman | M | 62 |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | 1 ans |
Randy Meier | M | 65 | 18 ans | |
Jing Qian | F | 48 | 4 ans | |
Philip Lo Scalzo | M | - | 17 ans | |
Karen Hunady | F | - | 2 ans | |
Rafael Fonseca | M | 57 | 1 ans | |
Andrew Oh | M | 53 | 2 ans | |
Adam Levy | M | - | 3 ans | |
Elizabeth Anderson | F | 66 | 5 ans | |
Willard Dere | M | 70 | 8 ans | |
Natalie Mount | M | - |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | 2 ans |
Athena Countouriotis | M | 52 | 1 ans | |
Drew Dennison | M | - |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | - |
Sheng Tang | M | 40 | 4 ans | |
Dennis Joseph Slamon | M | 75 | 10 ans | |
Matthew Cooper | M | - |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | - |
George Davis | M | 53 | 20 ans | |
V. Lawlis | M | 72 | 17 ans | |
May Kin Ho | M | 71 | 3 ans | |
Deborah Dunsire | M | 61 | 3 ans | |
Brian Mueller | M | 50 | 22 ans | |
Matt Roden | M | 53 | 5 ans | |
S. Gail Eckhardt | M | 66 | 4 ans | |
Mark Enyedy | M | 60 | 1 ans | |
Robert Hombach | M | 58 | 7 ans | |
Stuart Bunting | M | - | 16 ans | |
Jeff Ajer | M | 61 | 19 ans | |
Tim Tyson | M | 71 | 2 ans | |
Kenneth Anderson | M | 72 |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | 16 ans |
P. Joseph Campisi | M | - | 5 ans | |
David Pyott | M | 70 | 8 ans | |
Elaine Heron | M | 76 | 22 ans | |
Ann Li Lee | M | 63 | 6 ans | |
Jason Haas | M | 56 | 3 ans | |
Humaira Serajuddin | F | - | 2 ans | |
Erin Burkhart | F | 45 | 2 ans | |
Xiao-Jing Zhang | M | - | 2 ans | |
Ganesh Vedantham | M | - | 3 ans | |
Marni Kottle | F | - | - | |
Kimberly McCutcheon Jablonski | F | - | 2 ans | |
Brian Sun | M | 40 | 2 ans | |
Bruce Evans | M | 64 |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | - |
Mark Lewis | M | - |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | - |
Elena A. Prokupets | M | - |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | - |
Bruce Downey | M | 76 |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | - |
Henry Fuchs | M | 66 | 15 ans | |
Jim Jeffs | M | 71 |
TORL Biotherapeutics LLC
TORL Biotherapeutics LLC BiotechnologyHealth Technology TORL Biotherapeutics LLC is a clinical-stage biopharmaceutical company based in Culver City, CA. TORL Biotherapeutics LLC is focused on developing new antibodies, including monoclonal antibodies (mAbs) and drug conjugates (ADCs), to transform the lives of patients with various types of cancer. TORL has a strategic partnership with the Slamon Research Lab and has exclusive rights to a program of biologics-based drugs for novel cancer targets. The company's lead program, TORL-1-23, is an ADC directed towards cldn6 for patients with multiple cancers. In addition to this, TORL has four other clinical-stage antibody programs and is building a pipeline of novel ADCs and mAbs for cancers with high unmet medical needs. The company was founded by David Licata, and the CEO is Mark J. Alles. | 4 ans |
Kevin Kaijun Li | M | - |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | - |
Jeffrey Galik | M | - | 5 ans | |
Todd Kaloudis | M | - |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | 2 ans |
Eduardo Von Pervieux | M | - | 16 ans | |
Traci McCarty | F | - | - | |
Amy Wireman | F | - | 11 ans | |
Nicole Keith | F | - | 9 ans | |
Bobby Sandage | M | 70 |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | - |
Christopher Williams | M | - | - | |
Malcolm Salter | M | 84 |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | 2 ans |
Kevin Eggan | M | - | 4 ans | |
Dave Jacoby | M | - | 8 ans | |
Brad Glasscock | M | - | 12 ans | |
Brinda Balakrishnan | M | 44 | 8 ans | |
Sophia Park | F | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jacqualyn Fouse | M | 62 | 7 ans | |
Sol Barer | M | 76 | 25 ans | |
Robert Hugin | M | 69 | 19 ans | |
Thomas Daniel | M | 69 | 10 ans | |
Adora Ndu | M | 43 | 5 ans | |
Kevin Patrick Lynch | M | 59 | 10 ans | |
Garry Nicholson | M | 69 | 2 ans | |
Scott Smith | M | 61 | 10 ans | |
Timothy J. Smith | M | - | - | |
Gerald Quirk | M | 56 | 6 ans | |
Perry Karsen | M | 69 | 9 ans | |
Michael Bonney | M | 65 | 5 ans | |
Annette C. North | F | 58 | 3 ans | |
John Kelley | M | 70 |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | 4 ans |
Amir Nashat | M | 51 | 8 ans | |
Simeon George | M | 46 | 5 ans | |
Vicki Sato | M | 75 | 6 ans | |
Phillip Sharp | M | 79 | 10 ans | |
Timothy L. Miller | M | 67 |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | 18 ans |
Paolo Tombesi | M | 60 | 1 ans | |
Julia Haller | M | 69 | - | |
Carol Gallagher | M | 59 | 3 ans | |
Clarence Machado | M | 60 | 3 ans | |
Dana Hu-Lowe | M | - | 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 96 | 96,00% |
Chine | 6 | 6,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Mark Alles
- Réseau Personnel